Cargando…

Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial

BACKGROUND: We aimed to determine whether cerebral white matter hyperintensities (WMHs) can distinguish stroke survivors susceptible to rapid kidney function decline from intensive blood pressure (BP) lowering. METHODS AND RESULTS: The SPS3 (Secondary Prevention of Small Subcortical Strokes) trial r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeme, Jesse C., Pergola, Pablo E., Scherzer, Rebecca, Shlipak, Michael G., Catanese, Luciana, McClure, Leslie A., Benavente, Oscar R., Peralta, Carmen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405594/
https://www.ncbi.nlm.nih.gov/pubmed/30686103
http://dx.doi.org/10.1161/JAHA.118.010091
_version_ 1783401107874119680
author Ikeme, Jesse C.
Pergola, Pablo E.
Scherzer, Rebecca
Shlipak, Michael G.
Catanese, Luciana
McClure, Leslie A.
Benavente, Oscar R.
Peralta, Carmen A.
author_facet Ikeme, Jesse C.
Pergola, Pablo E.
Scherzer, Rebecca
Shlipak, Michael G.
Catanese, Luciana
McClure, Leslie A.
Benavente, Oscar R.
Peralta, Carmen A.
author_sort Ikeme, Jesse C.
collection PubMed
description BACKGROUND: We aimed to determine whether cerebral white matter hyperintensities (WMHs) can distinguish stroke survivors susceptible to rapid kidney function decline from intensive blood pressure (BP) lowering. METHODS AND RESULTS: The SPS3 (Secondary Prevention of Small Subcortical Strokes) trial randomized participants with recent lacunar stroke to systolic BP targets of 130 to 149 and <130 mm Hg. We included 2454 participants with WMH measured by clinical magnetic resonance imaging at baseline and serum creatinine measured during follow‐up. We tested interactions between BP target and WMH burden on the incidence of rapid kidney function decline (≥30% decrease from baseline estimated glomerular filtration rate at 1‐year follow‐up) and recurrent stroke. Rapid kidney function decline incidence was 11.0% in the lower‐BP‐target arm and 8.1% in the higher‐target arm (odds ratio=1.40; 95% CI=1.07–1.84). Odds ratio for rapid kidney function decline between lower‐ and higher‐target groups ranged from 1.26 in the lowest WMH tertile (95% CI, 0.80–1.98) to 1.71 in the highest tertile (95% CI, 1.05–2.80; P for interaction=0.65). Overall incidence of recurrent stroke was 7.9% in the lower‐target arm and 9.6% in the higher‐target arm (hazard ratio=0.80; 95% CI, 0.63–1.03). Hazard ratio for recurrent stroke in the lower‐target group was 1.13 (95% CI, 0.73–1.75) within the lowest WMH tertile compared with 0.73 (95% CI, 0.49–1.09) within the highest WMH tertile (P for interaction=0.04). CONCLUSIONS: Participants with higher WMH burden appeared to experience greater benefit from intensive BP lowering in prevention of recurrent stroke. By contrast, intensive BP lowering increased the odds of kidney function decline, but WMH burden did not significantly distinguish this risk. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00059306.
format Online
Article
Text
id pubmed-6405594
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64055942019-03-21 Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial Ikeme, Jesse C. Pergola, Pablo E. Scherzer, Rebecca Shlipak, Michael G. Catanese, Luciana McClure, Leslie A. Benavente, Oscar R. Peralta, Carmen A. J Am Heart Assoc Original Research BACKGROUND: We aimed to determine whether cerebral white matter hyperintensities (WMHs) can distinguish stroke survivors susceptible to rapid kidney function decline from intensive blood pressure (BP) lowering. METHODS AND RESULTS: The SPS3 (Secondary Prevention of Small Subcortical Strokes) trial randomized participants with recent lacunar stroke to systolic BP targets of 130 to 149 and <130 mm Hg. We included 2454 participants with WMH measured by clinical magnetic resonance imaging at baseline and serum creatinine measured during follow‐up. We tested interactions between BP target and WMH burden on the incidence of rapid kidney function decline (≥30% decrease from baseline estimated glomerular filtration rate at 1‐year follow‐up) and recurrent stroke. Rapid kidney function decline incidence was 11.0% in the lower‐BP‐target arm and 8.1% in the higher‐target arm (odds ratio=1.40; 95% CI=1.07–1.84). Odds ratio for rapid kidney function decline between lower‐ and higher‐target groups ranged from 1.26 in the lowest WMH tertile (95% CI, 0.80–1.98) to 1.71 in the highest tertile (95% CI, 1.05–2.80; P for interaction=0.65). Overall incidence of recurrent stroke was 7.9% in the lower‐target arm and 9.6% in the higher‐target arm (hazard ratio=0.80; 95% CI, 0.63–1.03). Hazard ratio for recurrent stroke in the lower‐target group was 1.13 (95% CI, 0.73–1.75) within the lowest WMH tertile compared with 0.73 (95% CI, 0.49–1.09) within the highest WMH tertile (P for interaction=0.04). CONCLUSIONS: Participants with higher WMH burden appeared to experience greater benefit from intensive BP lowering in prevention of recurrent stroke. By contrast, intensive BP lowering increased the odds of kidney function decline, but WMH burden did not significantly distinguish this risk. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00059306. John Wiley and Sons Inc. 2019-01-26 /pmc/articles/PMC6405594/ /pubmed/30686103 http://dx.doi.org/10.1161/JAHA.118.010091 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Ikeme, Jesse C.
Pergola, Pablo E.
Scherzer, Rebecca
Shlipak, Michael G.
Catanese, Luciana
McClure, Leslie A.
Benavente, Oscar R.
Peralta, Carmen A.
Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
title Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
title_full Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
title_fullStr Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
title_full_unstemmed Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
title_short Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
title_sort cerebral white matter hyperintensities, kidney function decline, and recurrent stroke after intensive blood pressure lowering: results from the secondary prevention of small subcortical strokes (sps3) trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405594/
https://www.ncbi.nlm.nih.gov/pubmed/30686103
http://dx.doi.org/10.1161/JAHA.118.010091
work_keys_str_mv AT ikemejessec cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial
AT pergolapabloe cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial
AT scherzerrebecca cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial
AT shlipakmichaelg cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial
AT cataneseluciana cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial
AT mcclurelesliea cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial
AT benaventeoscarr cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial
AT peraltacarmena cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial